Compound atlas
Performance

Cardarine

Also known as · GW-501516

PPARδ agonist
Half-life
24h
approx. mean t½
Dose range
10–20 mg
typical, not prescriptive
Category
Performance
primary use-case
Single-dose decay
t½ = 24h · first-order model
~4d
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m24h2d3d4d5d

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A PPARδ agonist (not a SARM) studied for endurance and fat oxidation. Development halted over cancer findings in long-term rodent studies; banned in sport.

Mechanism of action

Activates PPARδ to shift metabolism toward fatty-acid oxidation and endurance.

Typical protocol

10–20 mg orally once daily; note the rodent carcinogenicity signal.

Storage

Room temp, dry, away from light.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.